- Synapse Medicine’s Clinical Decision Support Technology analyzes drug-related risks based on each patient’s clinical characteristics and is examined for their impact on the effectiveness and efficiency of in-patient pharmacists.
- Synapse Medicine’s drug reconciliation tool is provided through integration with hospitals’ current EPIC EHR workflows.
- The study also has the potential to provide drug suitability improvements that will help reduce the risk of in-hospital and post-discharge ADRs.
NEW YORK, Oct. 6, 2022 /PRNewswire/ — Synapse Medicine, a leader in intelligent medical decision technology, announced today that it has completed a clinical study with Brigham & Women’s Hospital, Boston, MA, and Vanderbilt University Medical Center, Nashville. is featured. TN to measure the utility and effectiveness of its clinical decision support solutions and drug solutions software in the hospital environment. Chief investigator Dr. Jeffrey L. Schniper, MD, MPH, MHM, is a professor of medicine in the Brigham Division of General Internal Medicine and Primary Care and the Hospital Medicine Unit and Harvard Medical School.
The Impact of Synapse Medicine Decision Support on Inpatient Pharmacist Efficacy and Efficiency: A Hybrid Type 2 Implementation Study employs hospital pharmacists at two study sites who work with general medical care teams and approve inpatient medications. give. Participants will use Synapse Medicine’s point-of-care tool to analyze drug-related risks and optimize drug suitability. You will also perform drug assignment for newly admitted patients. The study will quantitatively and qualitatively measure the usefulness of Synapse Medicine AI-enabled clinical decision support and drug delivery tools to determine their effectiveness.
Use of real-time data for drug suitability
Healthcare systems have long been challenged by the task of optimizing drug regimens, an important aspect in the continuity of patient care. Incorrect drug history or inappropriate medication can impact healthcare provider efficiency, delay treatment, put patients at risk for preventable adverse drug events (ADEs), and result in high readmission rates. can contribute. Hospital-related ADEs are common and dangerous, and cost an estimated $28 billion annually to manage.
“Hospital patients often come to us with submedication, especially with many medications. However, we also encounter drugs that react with each other depending on the kidney function. Incorrect dosage or medications that are inappropriate for their multiple medical conditions,” he said. Sniper. “As we treat patients with serious illnesses, we also have a responsibility to address these long-standing drug problems and ensure we don’t start any new medications before we return home. Don’t pose a problem.”
Technology-enabled clinical decision support builds capacity and improves patient outcomes
dr Clement Gohrs, CEO and co-founder of Synapse Medicine, shared, “Customizing a patient’s medication regimen can be a time-consuming and complex process, but it is fundamental to ensuring patient safety and clinical success. ” “By collaborating with Brigham and Women’s Hospital and Vanderbilt University Medical Center, we are able to demonstrate how our drug decision support technology improves accuracy, creating more time for real patient care and creating value for everyone involved. Rationalization of retrieval processes.”
Synapse Medicine’s solutions are based on a technology platform that leverages machine learning and natural language processing. It combines real-time drug knowledge with clinical data to identify potential drug risks and anomalies that can lead to ADEs. The suite of clinical decision support tools empowers healthcare professionals to deliver better personalized care to patients. The study will evaluate prescribing analyses, drug monographs and drug prescribing solutions for efficiency and accuracy.
About Synapse Medicine
At Synapse Medicine, we believe in the success of medicine and are committed to making it possible for everyone.
To achieve this goal, we have built a comprehensive, global pharmaceutical knowledge base using algorithms to ensure the most reliable and up-to-date data. On the front-end, Synapse Medicine offers a SaaS platform and UI components used to prescribe, deliver, and manage medications throughout the patient journey.
At Synapse Medicine, we partner with the world’s leading hospitals and digital healthcare companies in the United States, Europe and Japan to transform today’s medical ecosystem into tomorrow’s pharmaceutical success.
- Weiss, AJ, Freeman, WJ, Heslin, KC & Barrett, ML, 2018. Adverse Drug Incidence in US Hospitals, 2010 vs. 2014. HCUP Statistical Brief, 234.
Media contact: [email protected]+33 (0)5 56 35 50 87
Source Synapse Medicine